H.‐J. Lisch

431 total citations
34 papers, 349 citations indexed

About

H.‐J. Lisch is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, H.‐J. Lisch has authored 34 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Cardiology and Cardiovascular Medicine and 8 papers in Physiology. Recurrent topics in H.‐J. Lisch's work include Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers), Lipid metabolism and disorders (7 papers) and Lipoproteins and Cardiovascular Health (5 papers). H.‐J. Lisch is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers), Lipid metabolism and disorders (7 papers) and Lipoproteins and Cardiovascular Health (5 papers). H.‐J. Lisch collaborates with scholars based in Austria and Germany. H.‐J. Lisch's co-authors include S. Sailer, H Braunsteiner, Oleh Hornykiewicz, Heinz Drexel, E Knapp, V. Mühlberger, Manfred Herold, Heinz Drexel, Josef R. Patsch and Alan D. Springer and has published in prestigious journals such as The Lancet, Diabetes Care and Brain Research.

In The Last Decade

H.‐J. Lisch

32 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H.‐J. Lisch Austria	8	186	105	59	58	56	34	349
M. M. C. Landgraf-Leurs Germany	10	187 1.0×	116 1.1×	77 1.3×	16 0.3×	15 0.3×	19	358
Claudio Liberman Chile	8	144 0.8×	54 0.5×	89 1.5×	20 0.3×	15 0.3×	21	298
Hiroyuki TOYOSHIMA Japan	10	136 0.7×	160 1.5×	48 0.8×	21 0.4×	14 0.3×	24	399
R Kato Japan	4	203 1.1×	35 0.3×	79 1.3×	50 0.9×	22 0.4×	11	377
K. Xiang China	11	190 1.0×	104 1.0×	254 4.3×	97 1.7×	12 0.2×	34	479
Maurice E. Fabiani Australia	8	172 0.9×	29 0.3×	109 1.8×	230 4.0×	21 0.4×	8	402
E.P. Dawson United States	8	64 0.3×	25 0.2×	127 2.2×	94 1.6×	22 0.4×	9	430
H. Ooms Belgium	11	181 1.0×	126 1.2×	139 2.4×	19 0.3×	13 0.2×	28	453
L Kazdová Czechia	9	75 0.4×	48 0.5×	158 2.7×	51 0.9×	14 0.3×	18	353
Trevor H. Thomas United Kingdom	14	113 0.6×	55 0.5×	198 3.4×	90 1.6×	9 0.2×	29	539

Countries citing papers authored by H.‐J. Lisch

Since Specialization

Citations

This map shows the geographic impact of H.‐J. Lisch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.‐J. Lisch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.‐J. Lisch more than expected).

Fields of papers citing papers by H.‐J. Lisch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.‐J. Lisch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.‐J. Lisch. The network helps show where H.‐J. Lisch may publish in the future.

Co-authorship network of co-authors of H.‐J. Lisch

This figure shows the co-authorship network connecting the top 25 collaborators of H.‐J. Lisch. A scholar is included among the top collaborators of H.‐J. Lisch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.‐J. Lisch. H.‐J. Lisch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Drexel, Heinz, et al.. (2008). Normalisierung der perinatalen Morbidität bei Gestationsdiabetes durch straffe Stoffwechseleinstellung. DMW - Deutsche Medizinische Wochenschrift. 113(7). 256–259.

Wohlfarter, Thomas, T Hopferwieser, E Knapp, et al.. (2008). Idiopathischer flottierender linksventrikulärer Thrombus. DMW - Deutsche Medizinische Wochenschrift. 116(21). 808–811. 1 indexed citations

Lisch, H.‐J., et al.. (2008). Stellenwert der Lipoproteinelektrophorese für die quantitative Bewertung von Plasmalipoproteinen. DMW - Deutsche Medizinische Wochenschrift. 111(49). 1888–1890.

Konwalinka, G, et al.. (1986). Effect of human plasmalipoproteins on erythropoietic progenitor cells in serum-free cultures. Annals of Hematology. 52(3). 191–195. 2 indexed citations

Dzien, Alexander, et al.. (1986). Stimulating effect of intermediate-density lipoproteins (IDL) from hyperlipemic plasma on hepatic lipase. Journal of Molecular Medicine. 64(11). 530–533. 2 indexed citations

Schönitzer, Diether, et al.. (1985). Autoimmunhämolyse durch Anti-Pr. Transfusion Medicine and Hemotherapy. 12(4). 181–184. 3 indexed citations

Schönitzer, Diether, et al.. (1985). [Autoimmune hemolysis caused by anti-Pr].. PubMed. 12(4). 181–4. 4 indexed citations

Lisch, H.‐J., et al.. (1983). [Lipoproteins, apolipoproteins, lipoprotein lipase, hepatic triglyceride lipase and lecithin cholesterol acyltransferase in patients with nephrotic syndrome].. PubMed. 113(25). 909–13. 5 indexed citations

Lisch, H.‐J., et al.. (1983). Lipoproteins, HDL-apolipoproteins, activities of hepatic lipase and lecithin-cholesterol acyltransferase in the plasma of patients with post-alcoholic end-stage liver cirrhosis. Journal of Molecular Medicine. 61(18). 929–931. 11 indexed citations

10.

Lisch, H.‐J., et al.. (1983). Defective HDL₂in Familial Hypercholesterolemia. Hormone and Metabolic Research. 15(8). 409–409. 1 indexed citations

11.

Lisch, H.‐J., et al.. (1982). Plasmalipoproteine bei Störungen der Schilddrüsenfunktion des Menschen. Journal of Molecular Medicine. 60(7). 337–342. 3 indexed citations

12.

Lisch, H.‐J., et al.. (1982). Effect of treatment on the concentration of lipoproteins and the postheparin-lipolytic activity in the plasma of noninsulin-dependent diabetics. Journal of Molecular Medicine. 60(11). 551–554. 7 indexed citations

13.

Lisch, H.‐J., et al.. (1978). Activation of adipose tissue lipoprotein lipase by lipoprotein fractions from normals and patients with type V hyperlipoproteinemia. Journal of Molecular Medicine. 56(21). 1067–1069. 1 indexed citations

14.

Lisch, H.‐J., S. Sailer, & H Braunsteiner. (1978). Beziehung zwischen der Plasmakonzentration der Lipoproteide hoher Dichte (HDL) und der intraven�sen Fettoleranz bei Normo- und Hypertriglyzerid�mikern. Journal of Molecular Medicine. 56(16). 797–800. 4 indexed citations

15.

Patsch, Wolfgang, H.‐J. Lisch, S. Sailer, & H Braunsteiner. (1978). Initial cholesterol esterif ication rate in hyperlipoproteinaemia: effects of triglyceride‐rich Iipoproteins. European Journal of Clinical Investigation. 8(4). 209–213. 11 indexed citations

16.

Lisch, H.‐J., Josef R. Patsch, S. Sailer, & H Braunsteiner. (1975). Comparison of the effects of halofenate (MK-185) and clofibrate on plasma lipid and uric acid concentration in hyperlipoproteinemic patients. Atherosclerosis. 21(3). 391–399. 2 indexed citations

17.

Lisch, H.‐J., et al.. (1974). Effect of body weight changes on plasma lipids in patients with primary hyperlipoproteinemia. Atherosclerosis. 19(3). 477–484. 4 indexed citations

18.

Lisch, H.‐J., P. Dittrich, S. Sailer, F. Sandhofer, & H Braunsteiner. (1973). Basale und Noradrenalin-(NA-)induzierte Lipolyse in isolierten Fettzellen des Menschen bei isocalorischer und hypocalorischer Di�t. Journal of Molecular Medicine. 51(14). 735–737. 7 indexed citations

19.

Lisch, H.‐J., et al.. (1968). Über die Wirkung vonl-Thyroxin auf die Aktivität der Monoaminoxydase (MAO) im Gehirn von Meerschweinchen. Journal of Molecular Medicine. 46(4). 208–209. 1 indexed citations

20.

Hornykiewicz, Oleh, et al.. (1967). Wirkung von Chlorpromazin (CPZ) und ?-Methyl-p-Tyrosin (?MpT) auf den Dopamin-(DA) Gehalt des nigro-stri�ren Systems. Naunyn-Schmiedeberg s Archives of Pharmacology. 257(3). 289–290. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact